C12N 9/2448
Licheninase
Official title: {Licheninase (3.2.1.73)}
C12N9/2448 (Licheninase) appears on 17 US grants and 27 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 27
- Assignees
- 20
- Inventors
- 73
- Latest grant
- 30 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 4 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 2 | 4 |
| 2022 | 2 | 1 |
| 2023 | 1 | 0 |
| 2024 | 2 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Solubilization of MSW with blend enzymes30 Jan 2024US 11,884,955 B2Renescience A/S
- Solubilization of MSW with blend enzymes16 Jan 2024US 11,873,522 B2Renescience A/S
- Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions10 Jan 2023US 11,549,104 B2Novozymes A/S
- Enzyme composition15 Nov 2022US 11,499,142 B2Dsm IP Assets B.V.
- Dishwashing compositions comprising polypeptides having beta-glucanase activity and uses thereof13 Sep 2022US 11,441,140 B2Henkel AG & Co. KGaA
- Dough composition comprising non-starch polysaccharide degrading enzymes20 Aug 2026US 2026/0240175 A1Kerry Group Services International Limited
- Variant polypeptide having glucanase activity29 Jan 2026US 2026/0028607 A1Kemin Industries, Inc.
- Novel polypeptide with glucanase activity11 Sep 2025US 2025/0283064 A1Cj Cheiljedang Corporation
- Circular use of food residues by microbial fermentation19 Dec 2024US 2024/0415139 A1Technische Universität München
- Enzyme composition15 Aug 2024US 2024/0271110 A1Dsm IP Assets B.V.
Most cited
By later US patents
- β-glucanase from a bacillus15US 6,541,233 B1Henkel Kommanditgesellschaft auf Aktien · 2003
- Lichenase and coding sequences14US 6,103,511 AUniversity of Georgia Research Foundation, Inc. · 2000
- Influenza antigens, vaccine compositions, and related methods11US 8,124,103 B2Fraunhofer USA, Inc. · 2012
- Recombinant carrier molecule for expression, delivery and purification of target polypeptides10US 8,173,408 B2Fraunhofer USA, Inc. · 2012
- Bacillus anthracis antigens, vaccine compositions, and related methods5US 8,277,816 B2Fraunhofer USA, Inc. · 2012